Home

Home
Home 2018-11-01T09:49:45+00:00

Empower Your Portfolio

Find microcap stocks early and often through discipline, patience and proven investing strategies.

Free Trial

Your No. 1 Source For Premium Organic Microcap Research Led By a Team with Decades of Experience

Armed with experienced analysts, a veteran investing team, and real-time data from our fintech partner Sentieo, GeoInvesting gives you the power to evaluate educated investing decisions with confidence. Whether you’re an experienced investor looking for high-impact idea generation or just looking to broaden your knowledge of investing, GeoInvesting can help with actionable insights on a wide array of stocks and commentary on the broader market.

GeoInvesting has worked diligently over the last decade to understand and benefit from working in areas that the Wall Street “crowd” has avoided – namely, microcap stocks. This niche of the market, while mostly ignored by analysts and financial media, is still often quietly invested in by many well-known billionaires. We track their holdings and apply our own proprietary analysis in the space to find pockets of information arbitrage and unnoticed opportunities that have acted as the backbone for our investing success for over a decade.

Since GeoInvesting’s inception in 2007, we’ve been helping investors understand companies better by interviewing management teams, dissecting conference calls, interacting with our wide network of investors and scouring financial documents for hidden clues. GeoInvesting provides quick, concise and efficient research instead hundreds of pages of meaningless boilerplate jargon to pore through. You will no longer have to sift through these documents to find the most relevant aspects of a company’s operations, results and guidance – that’s our promise.

Learn More

We guide our members through the investment process that we have used to pick stocks and perform research for over three decades.

Our Mission

To be the premier purveyor of due diligence and education on how to safely and effectively invest in the stock market.

Our Vision

To provide investors of all skill levels additional confidence to make educated considerations in the microcap stock world. Our goal is to help you understand how we simplify the investment process and minimize risk using proprietary strategies, discipline, patience and emotional intelligence.

Our Core Values

Wall Street’s 6 pillars are intended to portray a level of trust and dignity. Yet, time after time, this institution lets Main Street down. By contrast, we have constantly fought for the common investor with our own 6 pillars of trust.

Testimonials

See More Testimonials

Free Trial

Our premium services are designed to you show you how we perform stock research and why we invest in select micro-cap stocks. Our end goal is to give you the skill sets to become a better investor.  If you believe that fundamental investing is the winning approach, then you’ve come to the right place.

~ Maj  Soueidan, Full-time Investor & Co-Founder GeoInvesting

Calls To Action

Calls to Actions include alerts on the stocks our team is buying and selling. We always disclose why we make our investment decisions. We generally release about one CTA per week.

Model Portfolios

Model portfolios focus on specific proven strategies to help us substantially outperform the market. We employ several different themed approaches to manage risk and provide focus on what we believe are our best ideas.

Premium Research

GeoInvesting provides institutional-grade research that’s affordable to the everyday investor. Unlike Wall Street investment banks, we don’t get paid by companies to talk about them. The GeoTeam’s research has powered over 11 years of investing success.

Education

Let us show you how our experience and knowledge of legendary investors has shaped our stock picking skills and portfolio strategies. Learn how we find winning management teams of undiscovered micro-caps.

Case Studies

Our Insights

Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

By | December 12th, 2018|

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved treatments for hemophilia, expects to update investors on December 18, 2018 regarding its review of the neutralizing antibodies (nAB) observed [...]

Karyopharm’s Cancer Drug Achieves Impressive Results

By | December 2nd, 2018|

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 for its lymphoma drug candidate Selinexor, noting patients who experienced a complete or partial response in a 125-patient trial had [...]

Top